Form 8-K ARIAD PHARMACEUTICALS For: Dec 29
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
ARIAD Pharma (ARIA) Receives Payments from Bellicum (BLCM)
December 30, 2014 4:20 PM ESTAs previously disclosed, in October 2014, ARIAD Pharmaceuticals, Inc. (Nasdaq: ARIA) entered into an agreement with Bellicum Pharmaceuticals, Inc. (Bellicum) (Nasdaq: BLCM) to restructure and amend an existing license agreement between the companies for ARIADs cell-signaling technology. Under the... More
